THIAZOLIDINEDIONE COMPOUND

PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YOSHIDA SHIGERU, NEGORO KENJI, ONUKI KEI, BEITOKU YASUHIRO, KURAMOTO KAZUYUKI, KUROSAKI TOSHIO, IWASAKI FUMIYOSHI, SOGA TAKATOSHI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YOSHIDA SHIGERU
NEGORO KENJI
ONUKI KEI
BEITOKU YASUHIRO
KURAMOTO KAZUYUKI
KUROSAKI TOSHIO
IWASAKI FUMIYOSHI
SOGA TAKATOSHI
description PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2011016722A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2011016722A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2011016722A3</originalsourceid><addsrcrecordid>eNrjZJAK8fB0jPL38XTx9HN18fT3c1Vw9vcN8A_1c-FhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhoYGhmbmRkaOxkQpAgCIVyDZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIAZOLIDINEDIONE COMPOUND</title><source>esp@cenet</source><creator>YOSHIDA SHIGERU ; NEGORO KENJI ; ONUKI KEI ; BEITOKU YASUHIRO ; KURAMOTO KAZUYUKI ; KUROSAKI TOSHIO ; IWASAKI FUMIYOSHI ; SOGA TAKATOSHI</creator><creatorcontrib>YOSHIDA SHIGERU ; NEGORO KENJI ; ONUKI KEI ; BEITOKU YASUHIRO ; KURAMOTO KAZUYUKI ; KUROSAKI TOSHIO ; IWASAKI FUMIYOSHI ; SOGA TAKATOSHI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110127&amp;DB=EPODOC&amp;CC=JP&amp;NR=2011016722A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110127&amp;DB=EPODOC&amp;CC=JP&amp;NR=2011016722A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YOSHIDA SHIGERU</creatorcontrib><creatorcontrib>NEGORO KENJI</creatorcontrib><creatorcontrib>ONUKI KEI</creatorcontrib><creatorcontrib>BEITOKU YASUHIRO</creatorcontrib><creatorcontrib>KURAMOTO KAZUYUKI</creatorcontrib><creatorcontrib>KUROSAKI TOSHIO</creatorcontrib><creatorcontrib>IWASAKI FUMIYOSHI</creatorcontrib><creatorcontrib>SOGA TAKATOSHI</creatorcontrib><title>THIAZOLIDINEDIONE COMPOUND</title><description>PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAK8fB0jPL38XTx9HN18fT3c1Vw9vcN8A_1c-FhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhoYGhmbmRkaOxkQpAgCIVyDZ</recordid><startdate>20110127</startdate><enddate>20110127</enddate><creator>YOSHIDA SHIGERU</creator><creator>NEGORO KENJI</creator><creator>ONUKI KEI</creator><creator>BEITOKU YASUHIRO</creator><creator>KURAMOTO KAZUYUKI</creator><creator>KUROSAKI TOSHIO</creator><creator>IWASAKI FUMIYOSHI</creator><creator>SOGA TAKATOSHI</creator><scope>EVB</scope></search><sort><creationdate>20110127</creationdate><title>THIAZOLIDINEDIONE COMPOUND</title><author>YOSHIDA SHIGERU ; NEGORO KENJI ; ONUKI KEI ; BEITOKU YASUHIRO ; KURAMOTO KAZUYUKI ; KUROSAKI TOSHIO ; IWASAKI FUMIYOSHI ; SOGA TAKATOSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2011016722A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YOSHIDA SHIGERU</creatorcontrib><creatorcontrib>NEGORO KENJI</creatorcontrib><creatorcontrib>ONUKI KEI</creatorcontrib><creatorcontrib>BEITOKU YASUHIRO</creatorcontrib><creatorcontrib>KURAMOTO KAZUYUKI</creatorcontrib><creatorcontrib>KUROSAKI TOSHIO</creatorcontrib><creatorcontrib>IWASAKI FUMIYOSHI</creatorcontrib><creatorcontrib>SOGA TAKATOSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YOSHIDA SHIGERU</au><au>NEGORO KENJI</au><au>ONUKI KEI</au><au>BEITOKU YASUHIRO</au><au>KURAMOTO KAZUYUKI</au><au>KUROSAKI TOSHIO</au><au>IWASAKI FUMIYOSHI</au><au>SOGA TAKATOSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIAZOLIDINEDIONE COMPOUND</title><date>2011-01-27</date><risdate>2011</risdate><abstract>PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2011016722A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THIAZOLIDINEDIONE COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A43%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YOSHIDA%20SHIGERU&rft.date=2011-01-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2011016722A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true